Skip to main content

Belen Garcia Prats

My name is Belén Garcia Prats, I hold a Bachelor’s Degree in Biomedical Sciences. Currently, I am the in vivo laboratory technician at Drug Delivery and Targeting (DDT) group at VHIR, holding more than one year experience working with oncologic mouse models in an ISO900 environment.

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

Belen Garcia Prats

Institutions of which they are part

Research technician
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca

My name is Belén Garcia Prats, I hold a Bachelor’s Degree in Biomedical Sciences. Currently, I am the in vivo laboratory technician at Drug Delivery and Targeting (DDT) group at VHIR, holding more than one year experience working with oncologic mouse models in an ISO900 environment.

My name is Belén Garcia Prats, I hold a Bachelor’s Degree in Biomedical Sciences and I obtained in 2020 a MSc in Molecular Biotechnology. Hence, I am passionate about biomedical research areas such as pharmacology and toxicology, cancer biology and molecular techniques.
My previous experience encompasses working in a clinical laboratory, being in charge of the realization of biochemical and immunological analysis on clinical simples. In addition, I was parto f a basic research group, where I worked with cell cultures for the study of type 2 diabetes mellitus pathogenesis.
Currently, I am the in vivo laboratory technician at Drug Delivery and Targeting (DDT) group at VHIR. I have obtained the laboratory animals handling accreditation, holding more than one year experience working with oncologic mouse models in an ISO900 environment.

Projects

SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH..

IP: Simon Schwartz Navarro
Collaborators: Julia German Cortes, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Marc Miquel Moltó Abad, Maria Fidel Lledò, Olga Sánchez- Maroto Carrizo, Belen Garcia Prats, Diana Fernandes de Rafael
Funding agency: EUROPEAN COMMISSION
Funding: 649580
Reference: SAFE-N-MEDTECH_S.SCHWARTZ_H2020_2018
Duration: 01/04/2019 - 30/09/2023

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The new system, made of cellulose and chitosan, enables sustained release of docetaxel and has demonstrated antitumor activity in preclinical models of ovarian cancer and glioblastoma.

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

Related professionals

Eladia Montserrat Tauste Rubio

Eladia Montserrat Tauste Rubio

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Carla Carbonell Rosell

Carla Carbonell Rosell

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Roger Domingo Espinós

Roger Domingo Espinós

Research technician
Stroke research
Read more
Elia Rojas Montserrat

Elia Rojas Montserrat

Administration and Management
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.